Investor · Seattle, WA

Colleen Delaney

Open Colleen in the network graph →

Filings

5

SEC Form D

Connections

24

co-filers

Capital

$52.0M

across filings

Active

May 2018

to Jun 2024

Most-connected co-filers (24)

Michael Yurkowsky · Seattle, WA2 shared Philippe Deschamps · Newtown, PA1 shared Lawrence D. Gozlan · Seattle, WA1 shared Charles H. Farrahar · Cumming, GA1 shared Michael Sistenich · Seattle, WA1 shared Federico H. Pier · Cumming, GA1 shared Dorothy J. Jordan · Cumming, GA1 shared Gene L. Salkind · Shoreham, NY1 shared Daniel Yerace · Wexford, PA1 shared Christine Sheehy · Wexford, PA1 shared David Mehalick · Wexford, PA1 shared John Fitzpatrick · West Hills, CA1 shared Brian Cogley · Cranberry Twp, PA1 shared Christopher Cochran · Wexford, PA1 shared Tara M. Desilva · Wexford, PA1 shared Charlie Farrahar · Sawanee, GA1 shared Gary Christianson · Seattle, WA1 shared Kathleen Fanning · Seattle, WA1 shared Jim Johnson · Centennial, CO1 shared Jeffrey Wright · Perth, United Kingdom1 shared Christopher Calise · New York, NY1 shared Brian Daniels · Research Triangle Park, NC1 shared Steven Gillis · Lexington, MA1 shared Richard Rosenblum · Las Vegas, NV1 shared

Recent filings (5)

Coeptis Therapeutics Holdings, Inc.Jun 2024 · 20 co-filers$10.0M Coeptis Therapeutics Holdings, Inc.Jun 2024 · 20 co-filers$10.0M Deverra Therapeutics, Inc.Sep 2023 · 3 co-filers$2.4M Deverra Therapeutics, Inc.Sep 2023 · 3 co-filers$2.4M Vicapsys Life Sciences, Inc.Jul 2023 · 11 co-filers$330K Vicapsys Life Sciences, Inc.Jul 2023 · 11 co-filers$330K Deverra Therapeutics, Inc.Aug 2020 · 3 co-filers$3.5M Deverra Therapeutics, Inc.Aug 2020 · 3 co-filers$3.5M Nohla Therapeutics Inc.May 2018 · 15 co-filers$58.4M Nohla Therapeutics Inc.May 2018 · 15 co-filers$58.4M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Colleen in the interactive graph →